Universal-Beteiligungs- und Servicegesellschaft
BBIO icon

Universal-Beteiligungs- und Servicegesellschaft’s BridgeBio Pharma BBIO Stock Holding History

Universal-Beteiligungs- und Servicegesellschaft’s Portfolio BBIO Stock Details BBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.22M Sell
96,883
-102,762
-51% -$7.2M 0.01% 780
2026
Q1 		$14.8M Sell
199,645
-34,291
-15% -$2.49M 0.03% 475
2025
Q4 		$17.9M Buy
233,936
+11,620
+5% +$763K 0.03% 429
2025
Q3 		$11.5M Buy
222,316
+7,572
+4% +$369K 0.02% 555
2025
Q2 		$9.27M Buy
214,744
+50,683
+31% +$1.84M 0.02% 600
2025
Q1 		$5.67M Buy
+164,061
New +$5.53M 0.01% 766

Other funds holding BBIO

JT
Jupiter Topco New York $245B AUM
KKRC
Kohlberg Kravis Roberts & Co New York $5.71B AUM 72.37% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
ACM
Aisling Capital Management New York $472M AUM 106.83% 1-Year Est. Return

Universal-Beteiligungs- und Servicegesellschaft's BBIO Position: Q2 2026 in Review

Universal-Beteiligungs- und Servicegesellschaft reduced its BridgeBio Pharma (BBIO) stake by 51% in Q2 2026, selling an estimated $7.2M and leaving 96,883 shares worth $7.22M. The position accounts for 0.01% of the portfolio, ranked #780.

Universal-Beteiligungs- und Servicegesellschaft first reported a position in BBIO in Q1 2025 and has held it in 6 quarters since. The position peaked at $17.9M in Q4 2025. 474 funds tracked by Wall St. Rank hold BBIO as of Q2 2026.

  • Universal-Beteiligungs- und Servicegesellschaft held 96,883 shares of BridgeBio Pharma worth $7.22M as of Q2 2026.
  • Universal-Beteiligungs- und Servicegesellschaft sold 102,762 BridgeBio Pharma shares in Q2 2026, an estimated $7.2M.
  • BridgeBio Pharma made up 0.01% of Universal-Beteiligungs- und Servicegesellschaft's portfolio in Q2 2026, its #780 holding.
  • Universal-Beteiligungs- und Servicegesellschaft first reported a position in BridgeBio Pharma in Q1 2025 and has held it in 6 quarters since.
  • Universal-Beteiligungs- und Servicegesellschaft's BridgeBio Pharma position peaked at $17.9M in Q4 2025.
  • 474 funds tracked by Wall St. Rank held BridgeBio Pharma as of Q2 2026.

Based on Universal-Beteiligungs- und Servicegesellschaft's 13F filing for Q2 2026, filed 6 Aug 2026.